Evolving Strategies for the Management of BRAF-Mutant Metastatic Colorectal Cancer
BRAF Mutations in Colorectal Cancer: Clinical Relevance and Role in Targeted Therapy in: Journal of the National Comprehensive Cancer Network Volume 10 Issue 11 (2012)
The heterogeneous clinical and pathological landscapes of metastatic Braf-mutated colorectal cancer | Cancer Cell International | Full Text
BRAFV600E drives dedifferentiation in small intestinal and colonic organoids and cooperates with mutant p53 and Apc loss in transformation | Oncogene
BRAF Mutation in Colorectal Cancer | IntechOpen
Targeting BRAF Mutation Positive Cancers: Melanoma, Lung and Colorectal | Roswell Park Comprehensive Cancer Center - Buffalo, NY
Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR | Nature
Targeted Drug Trio for Colorectal Cancer with BRAF Mutations - NCI
A Vulnerability of a Subset of Colon Cancers with Potential Clinical Utility: Cell
The BRAF V600E mutation is an independent prognostic factor for survival in stage II and stage III colon cancer patients - Annals of Oncology
Frontiers | Management of BRAF Gene Alterations in Metastatic Colorectal Cancer: From Current Therapeutic Strategies to Future Perspectives
Management of BRAF-mutant metastatic colorectal cancer: a review of treatment options and evidence-based guidelines - Annals of Oncology
VisualAbstract: Encorafenib, Binimetinib, and Cetuximab in BRAF V600E–Mutated Colorectal Cancer | 2 Minute Medicine
BRAF Mutation in Colorectal Cancer Anita Turk, MD; Dustin Deming, MDDivision of Hematology and Oncology,Department of MedicineUniversity of Wisconsin-Madison School of Medicine and Public Health and University of Wisconsin Carbone Cancer Center,
BRAF V600E and SRC mutations as molecular markers for predicting prognosis and conversion surgery in Stage IV colorectal cancer | Scientific Reports
Immunohistochemical staining for BRAF V600E in colorectal cancer. (A-D)... | Download Scientific Diagram
72.03 Clinical Significance of BRAF Non-V600E Mutations in Colorectal Cancer - Academic Surgical Congress Abstracts Archive
Targeted Drug Trio for Colorectal Cancer with BRAF Mutations - NCI
Adaptive feedback signaling in BRAF V600E-mutated mCRC. (A) In BRAF... | Download Scientific Diagram
Exploring the best treatment options for BRAF-mutant metastatic colon cancer | British Journal of Cancer
SFPQ Depletion Is Synthetically Lethal with BRAFV600E in Colorectal Cancer Cells - ScienceDirect
BRAF V600E mutation is a predictive indicator of upfront chemotherapy for stage IV colorectal cancer
BRAF V600E mutations in right-side colon cancer: Heterogeneity detected by liquid biopsy - European Journal of Surgical Oncology
BRAF Biomarker | Colorectal Cancer Alliance
Frequency of RAS/BRAFV600E mutations by primary tumor site (AC,... | Download Scientific Diagram
Colorectal IHC portfolio
![PDF] Chapter 4 BRAF Mutation in Colorectal Cancer | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/31b2acb1c3014fd8b907cdddd384d814fa820614/7-Figure3-1.png "PDF] Chapter 4 BRAF Mutation in Colorectal Cancer | Semantic Scholar")